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Objectives The purpose of this study was to examine the effect of coronary artery calcium (CAC) on the classification of 10-
year hard coronary heart disease (CHD) risk and to empirically derive cut-off values of the calcium score for a
general population of elderly patients.
Background Although CAC scoring has been found to improve CHD risk prediction, there are limited data on its impact in
clinical practice.
Methods The study comprised 2,028 asymptomatic participants (age 69.6  6.2 years) from the Rotterdam Study. Dur-
ing a median follow-up of 9.2 years, 135 hard coronary events occurred. Persons were classified into low
(10%), intermediate (10% to 20%), and high (20%) 10-year coronary risk categories based on a Framingham
refitted risk model. In a second step, the model was extended by CAC, and reclassification percentages were
calculated. Cutoff values of CAC for persons in the intermediate-risk category were empirically derived based on
10-year hard CHD risk.
Results Reclassification by means of CAC scoring was most substantial in persons initially classified as intermediate risk. In
this group, 52% of men and women were reclassified, all into more accurate risk categories. CAC values above 615
or below 50 Agatston units were found appropriate to reclassify persons into high or low risk, respectively.
Conclusions In a general population of elderly patients at intermediate CHD risk, CAC scoring is a powerful method to reclas-
sify persons into more appropriate risk categories. Empirically derived CAC cutoff values at which persons at in-
termediate risk reclassified to either high or low risk were 615 and 50 Agatston units, respectively. (J Am Coll
Cardiol 2010;56:1407–14) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.06.029c
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rn primary prevention of coronary heart disease (CHD),
linical management is generally based on a person’s 10-year
HD risk as estimated by risk-scoring algorithms like the
ramingham risk score (FRS). Individuals are typically
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ccepted June 29, 2010.lassified into categories of low, intermediate, and high
0-year CHD risk and are treated accordingly. However,
isk-scoring algorithms appear to have limited accuracy to
dentify persons at high risk for developing CHD. Risk
rediction may be improved by use of noninvasive tests of
therosclerosis such as assessment of coronary artery calcium
CAC) by electron-beam tomography (EBT) scan, which is
nown to predict cardiovascular disease (1–8).
See page 1415
To establish the clinical value of a new test, an important
ssue is to assess the reclassification of individuals into
ifferent risk categories when the new test is added to
lassical risk factors (9). Additional testing for atheroscle-
osis is proposed to be most useful if applied to the
ntermediate-risk category (10% to 20% CHD risk in
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decisions are uncertain (10–12).
However, reclassification per-
centages for CAC and empiri-
cally derived CAC cutoff values
at which persons may be reclas-
sified to a more appropriate risk
category, based on 10-year CHD
risk data, are lacking.
In a population-based cohort
study among persons 55 years
of age with nearly 10-year
follow-up data, we studied the
usefulness of CAC to reclassify
individuals into more accurate
risk categories and derived em-
pirically based cutoff values of
CAC.
ethods
tudy population. The study was embedded in the Rot-
erdam Study, a prospective, population-based study among
ersons age 55 years and older in a municipality of Rotter-
am. The rationale and design of the Rotterdam Study have
een described elsewhere (13). The baseline examination
as completed between 1990 and 1993, followed by a
econd round between 1993 and 1995. The third examina-
ion took place from 1997 to 1999. From 1997 onward,
articipants through 85 years of age were invited to undergo
BT scanning of the heart to perform CAC scoring. This
as been referred to as the Rotterdam Coronary Calcifica-
ion study (8). The inclusion and exclusion of persons in the
tudy (response rate, 61%) have been described in detail by
liegenthart et al. (8). During the inclusion phase, the study
opulation was supplemented with inhabitants who reached
he age of 55 years after the baseline examination and
ersons aged 55 years and older who migrated into the
esearch area. Data were available for a total of 2,292
articipants. Of these, 252 participants had a history of
HD, defined as a history of clinically manifest myocardial
nfarction, coronary artery bypass grafting, or coronary
ngioplasty at the time of EBT scanning. Hence the current
nalysis was carried out in 2,040 asymptomatic subjects.
he Medical Ethics Committee of Erasmus Medical Cen-
er approved the study, and all participants gave informed
onsent.
AC. We assessed CAC in the epicardial coronary arteries
etected on EBT scans. Imaging was performed with a
-150 Imatron scanner (GE-Imatron). Before participants
ere scanned, they exercised adequate breath-holding.
rom the level of the root of the aorta through the heart, 38
mages were obtained with 100-ms scan time and 3-mm
lice thickness. We acquired images at 80% of the cardiac
ycle, using electrocardiogram triggering, during a single
Abbreviations
and Acronyms
AU  Agatston units
CAC  coronary artery
calcium
CHD  coronary heart
disease
CRP  C-reactive protein
EBT  electron-beam
tomography
FRS  Framingham risk
score
HDL  high-density
lipoprotein
NRI  net reclassification
improvementreath-hold. Quantification of CAC was performed with bccuImage software (AccuImage Diagnostics Corpora-
ion), displaying all pixels with a density above 130 HU. A
alcification was defined as a minimum of 2 adjacent pixels
ith a density over 130 HU. A CAC score was calculated
ccording to Agatston’s method (14). The trained scan
eaders were blinded to the clinical data of the participants.
he study protocol participants were not informed about
he CAC score.
ardiovascular risk factors. At the third examination,
nformation on medical history, drug use, and smoking
ehavior was collected using a computerized questionnaire.
nthropometric measures were obtained during the visit at
he research center. Blood pressure was measured at the right
rachial artery with a random-zero sphygmomanometer with
he participant in sitting position. The mean of 2 consecu-
ive measurements was used. After an overnight fast, blood
amples were obtained at the research center. Serum total
holesterol was determined by an automated enzymatic
rocedure using the CHOD-PAP reagent agent (Roche,
asel, Switzerland), and high-density lipoprotein (HDL)
as measured with the Roche HDL cholesterol assay using
olyethylene glycol–modified enzymes and dextran sulfate.
lucose was determined enzymatically by the Hexokinase
ethod. Diabetes was diagnosed based on a fasting plasma
lucose level7.0 mmol/l or use of antidiabetic medication.
-reactive protein (CRP) was measured in serum using a
ephelometric method (Immage, Beckman Coulter, Brea,
alifornia). Median duration between measurement of
ardiovascular risk factors and CAC scanning was 62 days.
linical outcomes. Information on fatal and nonfatal car-
iovascular end points was obtained from general practitio-
ers and letters and discharge reports from medical special-
sts. All events were classified by study physicians according
o the International Statistical Classification of Diseases and
elated Health Problems-10th Revision. The follow-up
rocedures have previously been described in detail (8).
welve participants were lost to follow-up, which left 2,028
articipants for analyses. As an outcome we used hard CHD
nonfatal myocardial infarction and CHD mortality). If a
onfatal event occurred within 28 days before CHD death,
he event was attributed to CHD mortality. Persons were
ollowed-up for a median time of 9.2 years (interquartile
ange 8.3 to 10.0 years).
tatistical analysis. We used a parametric Weibull propor-
ional hazards regression model that allows computation of
ndividual 10-year predicted risk of CHD from our available
.2 years of median follow-up duration. Hazard ratio
stimations from a Weibull model are very similar to those
rom a Cox model, both models being proportional hazards
egression models (15). We chose a Weibull model over the
ore frequently used Cox model because the latter cannot
stimate the 10-year cumulative incidence by extrapolation
f the actual median follow-up time of 9.2 years. In
ontrast, the Weibull model can make this extrapolation
ecause of its parametric nature. We fitted 2 Weibull
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October 19, 2010:1407–14 Coronary Calcium Improves CHD Risk Assessmentrediction models to the Rotterdam Study data: model 1,
eferred to as the “Framingham refitted” model, was based
n variables included in the Framingham risk function,
amely age, systolic blood pressure, antihypertensive med-
cation, total and HDL cholesterol, diabetes, and current
moking (16). Sex was used as a covariate in this model. We
hose to fit a model comprising Framingham risk factors on
ur data (Framingham refitted model) instead of using the
ramingham risk function (16) because previous research
howed that application of the Framingham risk function to
he elderly Rotterdam Study population led to systematic
verestimation of CHD risk in men (17). In a second step,
e extended the Framingham refitted model with the
atural logarithm of CAC ln(CAC1), model 2. We added
to all CAC values in order to deal with persons who had
CAC score of 0. We fitted this extended model to our data
nd compared the performance of these 2 models using the
ethods described in the next sections. In an extra analysis,
e examined the importance of CRP to enhance predictive
erformance of the Framingham refitted and the Framing-
am refitted plus CAC model. Because no evidence of a
onlinear effect was found, we added CRP as a linear term
o the models.
To determine the functional form used for each predictor,
e examined restricted cubic spline transformations for
ontinuous predictors (18) and used the likelihood ratio test
o examine the linearity assumption. If appropriate, we
hose the simplest form, usually a linear term. We assessed
he appropriateness of the Weibull survival time distribution
y plotting observed Kaplan-Meier survival curves based on
ard CHD events (n  135) against estimates from the
eibull model in strata of low, intermediate, and high
ramingham risk categories and found good agreement.
We compared global model fit using the likelihood ratio
hi-square test. To examine the discriminative ability each
odel, we calculated the optimism-corrected c-statistic
sing 150 bootstrap repetitions for each model by method of
arrell (18,19). Next, we computed reclassification percent-
ges to study the incremental ability of coronary calcium to
lassify subjects in risk categories according to commonly
sed categories of 10-year CHD risk: low (10%), inter-
ediate (10% to 20%), and high risk (20%) (20). Esti-
ated 10-year risks were calculated for each cell of the
eclassification table to show calibration of reclassified
bservations with observed risk. To evaluate true improve-
ent in classification by addition of coronary calcium to the
ramingham refitted model, we calculated the net reclassi-
cation improvement (NRI). The original method for
alculation of the NRI by Pencina et al. (21) was proposed
or binary data. In that case, the number of cases and
oncases is apparent. However, in survival data, the number
f cases and noncases at the time point of interest usually is
ot because not all persons have a complete follow-up. We
alculated the NRI with the expected number of cases, as
ecently proposed by Steyerberg and Pencina (22). For each
f the 3 risk categories, we first estimated the cumulative sncidence of hard CHD events at 10 years by use of Weibull
roportional hazard analysis. We then estimated the
bsolute number of cases in each category by multiplying
he cumulative incidence by the number of persons in
hat category. The number of noncases per category was
he total number of persons minus the number of cases.
n accordance with the original NRI calculation method,
ny “upward” movement in persons with an event implied
orrect reclassification, and any “downward” movement
ndicated incorrect reclassification. The interpretation
as opposite for people who did not develop events. The
et improvement in reclassification was quantified as the
roportion of correct minus the proportion of incorrect
eclassification.
Because additional calcium scoring is proposed to be most
seful if applied to the intermediate-risk category (10–12),
e derived coronary calcium cutoff values at which individ-
als at intermediate risk were reclassified into the high- or
ow-risk category. For this purpose, we included the Fra-
ingham risk categories as categorical and ln(CAC1) as a
inear term in the Weibull model. By means of a sex-CAC
nteraction, we examined the need for sex-specific CAC
utoff values.
Information on covariables was missing in up to 3.5% of
ersons, except for antihypertensive medication use, which
as missing in 24% of persons. Missing values were im-
uted using the multivariate imputation by chained equa-
ions (MICE) library of R, as described previously (17). All
nalyses were performed using SPSS version 12.01 for
indows (SPSS, Inc., Chicago, Illinois) and R version
.6.0 (R Foundation for Statistical Computing, Vienna,
ustria).
esults
aseline characteristics of the study population, overall and
y sex, are shown in Table 1. Mean age of the population at
aseline was 69.5 years, and 43% of patients were male.
uring the median follow-up duration of 9.2 years (25th to
5th percentile: 8.3 to 10.0 years), 503 persons died,
hereas 135 had their first hard coronary event (81 nonfatal
yocardial infarctions and 54 CHD deaths). The median
alcium score was 84 Agatston units (AU) (25th to 75th
ercentile: 8 to 382 AU).
Regression parameters of the Weibull models are dis-
layed in Table 2. Compared with the Framingham refitted
odel, addition of coronary calcium significantly improved
odel fit (likelihood ratio chi-square increase: 36.4; p 
.001). The c-statistic improved significantly from 0.72 to
.76, indicating better average discriminative ability of the
odel including coronary calcium.
In an extra analysis, we examined the importance of CRP
o enhance predictive performance of the Framingham
efitted model and found that addition of CRP did not
esult in a significant improvement of the c-statistic (c-
tatistic FRS  CRP model: 0.72 compared with 0.72 of
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Coronary Calcium Improves CHD Risk Assessment October 19, 2010:1407–14he FRS model alone; p  0.31). Furthermore, CRP did
ot significantly improve the c-statistic of the FRS  CAC
odel (c-statistic FRS  CAC  CRP model: 0.76
ompared with 0.76 of the FRS  CAC model; p  0.61).
Persons stratified according to categories of estimated
0-year hard CHD risk based on the Framingham refitted
odel and after adding CAC to that model are presented in
ables 3 and 4. In men, percentages in the low-,
ntermediate-, and high-risk categories were 54%, 33%, and
3%, respectively; for women these percentages were 83%,
5%, and 2%, respectively. The largest proportions of
eclassified persons were seen in the intermediate Framing-
am risk group (n  451; 22% of the total population).
mong men, 51% were reclassified: 30% moved to the
ow-risk category, and 21% moved to the high-risk group.
n women at intermediate risk, 53% were reclassified, with
9% moving downward and 24% moving upward in risk.
eclassification percentages were generally smaller in per-
ons initially classified as low or high with the Framingham
efitted model. In men at low Framingham risk, 15% moved
o the intermediate-risk group, but only 2 persons moved to
he high-risk group; among women in the low-risk group,
% moved to the intermediate-risk group, and 2 persons
oved to the high-risk group. In men at Framingham high
isk, 28% moved to the intermediate-risk group and 5%
oved to the low-risk group; in women these percentages
ere 36% and 3%, respectively. Generally, point estimates
f the observed risks agreed with the corresponding cate-
ories of predicted risk, indicating good calibration. How-
aseline Characteristics of the Study PopulationTable 1 Baseline Characteristics of the Study Population
Variable
All
(n  2,028)
Men
(n  864)
Women
(n  1,164)
Age, yrs 69.6 6.2 69.5 6.1 69.7 6.3
Male, % 42.6
Body mass index, kg/m2 27.1 4.0 26.5 3.2 27.5 4.5
Systolic blood pressure,
mm Hg
143 21 144 21 143 21
Diastolic blood pressure,
mm Hg
76 11 78 12 75 11
Antihypertensive
medication, %
27.6 23.4 30.4
Total cholesterol, mmol/l 5.9 1.0 5.7 1.0 6.0 0.9
HDL cholesterol, mmol/l 1.4 0.4 1.3 0.3 1.5 0.4
Cholesterol-lowering
medication, %
14.0 12.0 15.2
Smokers, %
Current 16.8 19.1 15.1
Former 52.0 68.9 39.6
Serum glucose, mmol/l 5.9 1.5 6.0 1.6 5.8 1.4
Antidiabetic medication, % 6.5 8.0 5.4
Family history of MI, % 18.4 17.0 19.6
Calcium score, AU 84 (8–382) 191 (35–623) 37 (3–210)
Persons without CAC, % 10.5 3.8 15.5
ategorical variables are presented as percentage. Continuous values are expressed as mean  SD.
edian (25th to 75th percentiles) is presented in case of skewed distribution.
CAC  coronary artery calcium; HDL  high-density lipoprotein; MI  myocardial infarction.ver, in some groups calibration assessment was hampered
*y small numbers of reclassified persons. In all persons,
ddition of CAC to the Framingham refitted model signif-
cantly improved risk classification, as indicated by an NRI
f 0.14 (p  0.01).
Figure 1 displays the association of individual CAC
cores against 10-year predicted risk of CHD in persons at
ntermediate Framingham risk. Because there was no evi-
ence of a sex-specific prognostic effect of CAC (p 0.55),
n overall curve is presented. Empirically derived cutoff
alues correspond to the cross-section of the curve with the
ow- and high-risk demarcation. CAC scores above 615
U and below 50 AU suggest reclassification to the high-
r low-risk stratum, respectively.
iscussion
his population-based study among persons 55 years of
ge, with almost 10 years of follow-up, shows that adding
AC to the Framingham risk model leads to substantial
eclassification between CHD risk categories, especially in
ersons at intermediate Framingham risk. More than 50%
f both men and women in the intermediate-risk group
ere reclassified into the high- or low-risk category. The
mpirically derived cutoff values at which individuals moved
rom the intermediate to the high- or the low-risk group
ere 615 and 50 AU, respectively.
Noninvasive assessment of atherosclerosis is regarded as
ost useful in persons classified as intermediate Framing-
am risk, in which treatment decisions are uncertain
10–12). In our study, reclassification by additional CAC
esting was particularly high in the intermediate-risk group,
n which 52% of persons (men and women combined) were
eclassified (30% to the low-risk and 22% to high-risk
roup). This is in accordance with the findings of a recent
opulation-based cohort study by the MESA (Multi-
thnic Study of Atherosclerosis) among 5,878 individuals
ho were free of CVD at baseline (mean age 62 years, 46%
arameter Estimates and Performance Measures ofhe Framingha R fitted and the Framingham PlusAC Models
Table 2
Param ter Estimates d Perfor ance Measures of
the Framingham Refitted and the Framingham Plus
CAC Models
Parameter
Framingham Framingham  CAC
HR 95% CI HR 95% CI
Age* 2.64 1.97–3.52 2.09 1.54–2.83
Male sex 1.61 1.12–2.32 1.18 0.81–1.72
Systolic blood pressure 1.02 0.94–1.11 1.01 0.93–1.10
Anti-HT medication use 1.23 0.85–1.80 1.06 0.73–1.56
Total cholesterol 1.19 1.00–1.43 1.17 0.97–1.40
HDL cholesterol 0.30 0.17–0.53 0.31 0.18–0.54
Diabetes 1.25 0.75–2.08 1.15 0.69–1.91
Current smoking 1.66 1.09–2.52 1.46 0.95–2.23
ln(CAC1) 1.33 1.21–1.47
Performance measures
Likelihood chi-square 83.93 120.32 p  0.001
c-statistic 0.72 0.76 p  0.001HR per 10 years of increase in age instead of per 1-U increase.
CAC  coronary artery calcium; HDL  high-density lipoprotein; HT  hypertension.
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raditional risk factors using a 5-year CHD risk prediction
odel (23). In this study, the reclassification proportion in
he intermediate-risk group was 55% (39% to the low-risk
nd 16% to high-risk group). Reclassification percentages
y addition of CAC in the intermediate-risk group are
uch higher than those reported for adding ankle brachial
ndex to classical risk factors in a recent meta-analysis study
24). In this study, 4% of men and 10% of women at
ntermediate risk were reclassified after adding ankle bra-
hial index to the risk model. The Women’s Health Study
reviously reported 19% reclassification for CRP in women
t intermediate risk (25). The Framingham offspring study
eported 23% reclassification by addition of CRP in this
roup (26). Reclassification percentages were smaller in the
Cardiovascular Risk Reclassification ComparingRefitted Model With the Model Additionally InclTable 3 Card ovascu r Risk ReclassificatioRefitted Model With the Model Add
Framingham Refitted
10-Year Risk Categories
Framingham Refitted
<10%
10%
n  1,438 1,278 (88%) 1
Observed risk (95% CI) 0.03 (0.02–0.05) 0.
10%–20%
n  451 134 (30%) 2
Observed risk (95% CI) 0.09 (0.05–0.16) 0.
20%
n  144 7 (5%)
Observed risk (95% CI) 0.49 (0.15–0.94) 0.
CAC  coronary artery calcium; CI  confidence interval; NA  not ap
Cardiovascular Risk Reclassification ComparingWith the Model Additionally In ludi g CAC, by GTable 4 Card ovascu r Risk ReclassificatioWith the Model Additionally Includi
Framingham Refitted
10-Year Risk Categories
Framingham Refitted
<10%
Men
10%
n  467 394 (85%)
Observed risk (95% CI) 0.04 (0.02–0.06) 0
10%–20%
n  281 84 (30%) 1
Observed risk (95% CI) 0.04 (0.01–0.12) 0
20%
n  116 6 (5%)
Observed risk (95% CI) 0.57 (0.19–0.97) 0
Women
10%
n  966 879 (91%)
Observed risk (95% CI) 0.03 (0.02–0.05) 0
10%–20%
n  170 50 (29%)
Observed risk (95% CI) 0.17 (0.08–0.32) 0
20%
n  28 1 (3%)
Observed risk (95% CI) NA 0Abbreviations as in Table 3.nitial low- and high-risk groups. In men at low Framing-
am risk, 15% moved to the intermediate-risk group, but
nly 2 persons moved to the high-risk group; among women
n the low-risk group, 9% moved to the intermediate-risk
roup and 2 persons moved to the high-risk group. In men
t Framingham high risk, 28% moved to the intermediate-
isk group and 5% moved to the low-risk group; in women
hese percentages were 36% and 3%, respectively. Overall,
2% of persons in the low-risk group and 34% of persons in
he high-risk group were reclassified. These percentages are
omparable to those in the recent MESA, which reported
1% reclassification in the low-risk group and 36% reclas-
ification in the high-risk group (23). At present, it is
ncertain whether the decline in absolute risk has treatment
mplications because there is no evidence that intensive
FraminghamCACpari the Framingham
lly Including CAC
C 10-Year Risk Categories
n (%) Reclassified–20% >20%
%) 4 (1%) 160 (12%)
8–0.20) NA
%) 101 (22%) 235 (52%)
0–0.20) 0.29 (0.20–0.41)
%) 95 (66%) 49 (34%)
5–0.31) 0.31 (0.21–0.44)
e.
Framingham Refitted Modelrpari the Framingham Refitted Model
C, by Gender
C 10-Year Risk Categories
n (%) Reclassified–20% >20%
%) 2 (0%) 73 (15%)
06–0.24) NA
%) 60 (21%) 144 (51%)
09–0.23) 0.32 (0.20–0.48)
%) 78 (67%) 38 (33%)
05–0.36) 0.33 (0.22–0.47)
) 2 (0%) 87 (9%)
08–0.24) NA
%) 41 (24%) 91 (53%)
08–0.32) 0.26 (0.14–0.45)
%) 17 (61%) 11 (39%)
02–0.61) 0.24 (0.09–0.58)theudingn Com
itiona
 CA
10%
56 (11
13 (0.0
16 (48
14 (0.1
42 (29
13 (0.0theenden Com
ng CA
 CA
10%
71 (15
.12 (0.
37 (49
.15 (0.
32 (28
.13 (0.
85 (9%
.14 (0.
79 (47
.13 (0.
10 (36
.12 (0.
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t high Framingham risk (10,11).
Other studies have shown an effect of CAC testing on
HD risk assessment in Framingham risk categories, but
id not present reclassification percentages (1,5). Two
ross-sectional studies showed that the use of calcium
esting enabled identification of a higher risk subset among
ntermediate-risk individuals (4,6). Finally, a study among
atients referred for calcium screening by primary care
hysicians showed that CAC scoring is an effective risk
tratification tool in both young and elderly subjects (7).
imitations of this study are the use of self-reported,
ategorical risk factors, the possibility of referral bias, and
he use of total mortality rather than CHD events as
utcome. CAC cutoff values at which individuals reclassify
o another risk category are a prerequisite for incorporation
f CAC testing in clinical practice. However, currently used
utoff values are not based on empirical data. A recent study
y MESA found that using predefined absolute CAC cutoff
alues of 1, 100, and 400 AU performed better than age-,
ex-, and race/ethnicity-specific percentiles in terms of
odel fit and discrimination. However, this study had a
edian of 3.75 years of follow-up and therefore no empir-
cally derived absolute cutoff values for classification of
0-year CHD risk (27). To our knowledge, we are the first
o have estimated CAC cutoff values based on nearly 10
ears of follow-up. Our empirically derived upper cutoff
alue of 615 AU seems to be higher than the commonly
sed cutoff values of 400 AU, whereas our lower cutoff value
f 50 AU seems to be lower than the commonly use cutoff
f 100 AU. However, our cutoff values need to be validated
Figure 1 10-Year Absolute CHD Risk Estimation by CAC Score
Empirically derived cutoff values at which persons reclassified to either high or low
CAC  coronary artery calcium; CHD  coronary heart disease.n other large, population-based studies to further establish mhether empirically based cutoffs are indeed different from
he arbitrary cutoffs of 400 and 100 AU. Furthermore, one
hould realize that these cutoff values refer only to men and
omen in the intermediate-risk group that comprised 33%
f men and only 15% of women. Using lower boundaries for
ntermediate-risk category in women would lead to more
omen eligible to undergo calcium scoring. However, we
ased our definition of the intermediate-risk group (10% to
0% 10-year CHD risk) on widely used guidelines (20).
he contention that CAC testing may be useful for refining
isk assessment in women at low to intermediate risk (5% to
0%) has been suggested based on cross-sectional data (28)
nd an analysis of the MESA based on 24 soft and hard
ncident CHD events (29).
tudy strengths. Strengths of the current study include a
arge, unselected sample of asymptomatic individuals and an
lmost 10-year follow-up period. Our cohort provided the
pportunity to study the impact of CAC testing on risk
lassification for hard CHD events and to derive cutoff
alues at which persons were reclassified to other risk
ategories. Moreover, participants were unaware of their
alcium score; therefore, change in lifestyle or medication
se or additional cardiac testing on the basis of the calcium
core was unlikely to occur.
tudy limitations. Limitations of our study also need to be
ddressed. First, because previous research within the Rot-
erdam study showed that application of the Framingham
isk function led to systematic overestimation of CHD risk
n men (17), we chose to fit a model based on Framingham
isk factors to stratify our population in the well-known risk
ategories. A potential drawback is over-fitting of the
e Persons at Intermediate Risk (n  451)
ere 615 and 50 AU, respectively.of th
risk wodel, which could lead to underestimation of the addi-
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f both the Framingham and the Framingham plus CAC
odel were corrected for over-optimism using the bootstrap
ethod, as described in the Methods section. Second, the
odel extended with CAC calibrated generally well with
bserved risks, except in categories with small numbers. We
omputed 95% confidence intervals to show plausible ranges
f observed risk. Third, in order to comply with current
uidelines, we extrapolated CHD risk estimates to 10-year
isk from an actual follow-up period of 9.2 years using a
arametric survival modeling approach. Although the accu-
acy of the extrapolation cannot be verified, large deviations
re very unlikely because the actual follow-up time is so
lose to 10 years. Fourth, we estimated empirically based
utoff points for CAC suitable for our population. Of
ourse, accruing data is needed to validate this finding
efore it can be applied in the clinical setting of primary
revention. Furthermore, the ultimate judgment about the
election of persons undergoing CAC scoring and subse-
uent implications regarding clinical management should
lso be based on randomized clinical trials and cost-
ffectiveness analyses. Finally, our study was performed in
lder persons. The predictive power of traditional cardio-
ascular risk factors decreases with age, whereas increased
AC can be seen as a cumulative measure of the effect of
ifetime exposure to cardiovascular risk factors on the
rterial vessel wall and may therefore improve risk stratifi-
ation, particularly at older age. This implies that our results
hould not automatically be generalized to a younger
opulation.
onclusions
n a general population of elderly patients at intermedi-
te CHD risk, CAC scoring is a powerful method to
eclassify persons into more appropriate risk categories.
n the basis of CAC testing, more than 50% of an
symptomatic older population at intermediate risk was
eclassified as having either low or high risk of hard CHD
vents. Empirically derived CAC cutoff values at which
ersons at intermediate risk reclassified to high or low
isk were 615 and 50 AU, respectively.
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